VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 510 filers reported holding VALEANT PHARMACEUTICALS INTL in Q4 2014. The put-call ratio across all filers is 1.37 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $266,000 | +6.8% | 10,836 | -12.4% | 0.02% | +4.5% |
| Q2 2016 | $249,000 | -26.5% | 12,374 | -4.1% | 0.02% | +37.5% |
| Q1 2016 | $339,000 | -97.5% | 12,899 | -81.4% | 0.02% | -97.1% |
| Q1 2015 | $13,808,000 | -82.7% | 69,520 | -88.6% | 0.54% | -82.2% |
| Q3 2014 | $79,778,000 | -47.3% | 608,065 | -49.3% | 3.07% | -58.6% |
| Q2 2014 | $151,283,000 | – | 1,199,511 | – | 7.40% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |